Stokes Family Office’s Sanofi SNY Stock Holding History

Stokes Family Office’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$330K	Sell	7,732 -772	-9%	-$34.5K	0.04%	222
2026 Q1	$410K	Sell	8,504 -1,357	-14%	-$63.3K	0.04%	203
2025 Q4	$478K	Buy	+9,861	New	+$489K	0.04%	197
2025 Q2	–	Sell	-3,928	Closed	-$218K	–	245
2025 Q1	$218K	Sell	3,928 -5,707	-59%	-$309K	0.02%	221
2024 Q4	$465K	Buy	+9,635	New	+$490K	0.05%	166
2023 Q4	–	Sell	-11,620	Closed	-$623K	–	322
2023 Q3	$623K	Buy	11,620 +1,751	+18%	+$93.4K	0.07%	167
2023 Q2	$532K	Buy	9,869 +808	+9%	+$43.5K	0.06%	169
2023 Q1	$493K	Buy	9,061 +137	+2%	+$6.66K	0.06%	171
2022 Q4	$432K	Buy	8,924 +2,893	+48%	+$127K	0.06%	181
2022 Q3	$229K	Buy	6,031 +5	+0.1%	+$223	0.03%	237
2022 Q2	$301K	Buy	+6,026	New	+$320K	0.04%	207

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Stokes Family Office's SNY Position: Q2 2026 in Review

Stokes Family Office reduced its Sanofi (SNY) stake by 9.1% in Q2 2026, selling an estimated $34.5K and leaving 7,732 shares worth $330K. The position accounts for 0.04% of the portfolio, ranked #222.

Stokes Family Office first reported a position in SNY in Q2 2022 and has held it in 11 quarters since. The position peaked at $623K in Q3 2023. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Stokes Family Office held 7,732 shares of Sanofi worth $330K as of Q2 2026.
Stokes Family Office sold 772 Sanofi shares in Q2 2026, an estimated $34.5K.
Sanofi made up 0.04% of Stokes Family Office's portfolio in Q2 2026, its #222 holding.
Stokes Family Office first reported a position in Sanofi in Q2 2022 and has held it in 11 quarters since.
Stokes Family Office's Sanofi position peaked at $623K in Q3 2023.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Stokes Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.